After An 80% Correction, IS Rivian Automotive Inc (NASDAQ: RIVN) a buy ?

After An 80% Correction, IS Rivian Automotive Inc (NASDAQ: RIVN) a buy ?

ByMarketFacts

Rivian Automotive, Inc. (NASDAQ: RIVN) designs, develops and manufactures category-defining electric vehicles and accessories. Rivian is developing an electric SUV and pickup truck based on a “skateboard” that can support future vehicles or be adopted by other companies. The company is also building an electric delivery van as part of a partnership with Amazon. It plans to build an exclusive charging network in the United States and Canada by the end of 2023.

Is it the right time to exit AeroClean Technologies Inc (NASDAQ: AERC) ?

Is it the right time to exit AeroClean Technologies Inc (NASDAQ: AERC) ?

ByMarketFacts

AeroClean Technologies, Inc. (NASDAQ: AERC) an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. It provides Pūrgo, an air sanitization product for indoor spaces; and Pūrgo Lift that provides air purification solution for elevators and other wall-mount applications. The company’s products use SteriDuct, a proprietary technology that safely optimizes UV exposure to effectively remove and destroy organic airborne pathogens.

Are Novavax’s protein technology Covid shots & omicron-fighting prototype worth Investing : Novavax, Inc. (NASDAQ: NVAX) ?

Are Novavax’s protein technology Covid shots & omicron-fighting prototype worth Investing : Novavax, Inc. (NASDAQ: NVAX) ?

ByMarketFacts

Novavax, Inc (NASDAQ: NVAX) is a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Prior to 2020, company developed experimental vaccines for influenza and respiratory syncytial virus, as well as Ebola and other emerging infectious diseases.

Where is this air filtration technology stock heading: AeroClean Technologies Inc (NASDAQ: AERC )

Where is this air filtration technology stock heading: AeroClean Technologies Inc (NASDAQ: AERC )

ByMarketFacts

AeroClean Technologies, Inc. (NASDAQ: AERC) an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. The company offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. It provides Pūrgo, an air sanitization product for indoor spaces; and Pūrgo Lift that provides air purification solution for elevators and other wall-mount applications. The company’s products use SteriDuct, a proprietary technology that safely optimizes UV exposure to effectively remove and destroy organic airborne pathogens.